Health Care & Life Sciences » Biotechnology | Axovant Sciences Ltd.

Axovant Sciences Ltd.

Axovant Sciences Ltd.
Stock Exchange New York Stock Exchange
EPS
$1.89
Market Cap
$247.82 M
Shares Outstanding
122.08 M
Public Float
32.13 M

Profile

Address
11-12 St. James's Square
London London & South East SWIY 4LB
United Kingdom
Employees -
Website http://www.axovant.com
Updated 09/14/2018
Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel therapeutics in the fields of neurology and psychiatry. Its therapeutic focus are Parkinson's Disease and Lewy Body Dementia. It operates through the following geographical sgements: United States, Switzerland, Bermuda, and Other.

Financials

View All

Vivek Ramaswamy
Chairman
Ilan Oren
Director